日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EMCV Non-Structural Protein 2C Antagonizes cGAS-STING-Mediated Type I Interferon Signaling via Promoting K48-Linked Polyubiquitination and Degradation of STING

EMCV非结构蛋白2C通过促进STING的K48连接多聚泛素化和降解来拮抗cGAS-STING介导的I型干扰素信号通路。

Cheng, Rongrong; Dong, Pingan; Xing, Wei; Jin, Hongyuan; Ma, Tingting; Xie, Jingying; Wen, Yanqiao; Su, Bixiu; Li, Xiangrong; Feng, Ruofei

YWHAZ downregulated innate immune responses to RNA viruses by inhibiting the IRF3 signaling pathway

YWHAZ通过抑制IRF3信号通路下调对RNA病毒的先天免疫反应。

Li, Shasha; Han, Jinyuan; Wang, Hefei; Hou, Jixia; Wang, Linhao; Hou, Zhengyang; Zhang, Yaxin; Dou, Xueer; Xie, Jingying; Li, Huixia; Li, Xiangrong; Feng, Ruofei

Gallic acid inhibits EMCV infection via targeting the interaction between TBK1 and IRF3 to promote IFN-β expression

没食子酸通过靶向TBK1和IRF3之间的相互作用来促进IFN-β表达,从而抑制EMCV感染。

Zhang, Yan; Wen, Yanqiao; Xue, Weijiao; Zhang, Tengyu; Hou, Jixia; Chen, Xuewen; Feng, Ruofei; Tan, Chunxia

ICAM-1-mediated Src signaling pathway plays a pivotal role in encephalomyocarditis virus entry.

ICAM-1介导的Src信号通路在脑心肌炎病毒入侵中起着关键作用

Lian Ruiya, Dou Xueer, Wang Na, Li Shasha, Xie Jingying, Li Xiangrong, Yang Yanmei, Wen Yanqiao, Li Huixia, Feng Ruofei

An RNAi Therapy That Attenuates Multi-Organ Viremia and Improves Animal Survival in a Lethal EMCV Challenge Model

一种RNAi疗法可减轻多器官病毒血症并提高致命性EMCV攻击模型中动物的存活率

Zhang, Yaxin; Yue, Jiayu; Wu, Bei; Xie, Jingying; Xu, Jiying; Gao, Wenqing; Feng, Ruofei; Idris, Adi

Improvement of chicken plasma protein hydrolysate angiotensin I-converting enzyme inhibitory activity by optimizing plastein reaction

通过优化 plastein 反应提高鸡血浆蛋白水解物对血管紧张素 I 转化酶的抑制活性

Gao, Dandan; Guo, Penghui; Cao, Xin; Ge, Lili; Ma, Hongxin; Cheng, Hao; Ke, Yiqiang; Chen, Shien; Ding, Gongtao; Feng, Ruofei; Qiao, Zilin; Bai, Jialin; Nordin, Nurul I; Ma, Zhongren